About
Acutus is focused on the production of left-heart access products under its distribution agreement with
Investor Contact: |
D: 442-232-6080 |
investors@acutus.com |
Source:
2023 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.041 USD | -18.00% | -66.67% | -79.69% |
05-13 | Acutus Medical, Inc.(NasdaqCM:AFIB) dropped from S&P TMI Index | CI |
05-09 | Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M | MT |
About
Acutus is focused on the production of left-heart access products under its distribution agreement with
Investor Contact: |
D: 442-232-6080 |
investors@acutus.com |
Source:
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-79.69% | 1.22M | |
+8.29% | 124B | |
-5.61% | 11.17B | |
+4.83% | 9.17B | |
+39.60% | 5.59B | |
-22.04% | 4.71B | |
+8.39% | 3.44B | |
-6.28% | 2.88B | |
-10.23% | 2.11B | |
-5.99% | 2.09B |